A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer
dc.contributor.author | León-Letelier, Ricardo A. | |
dc.contributor.author | Chen, Yihui | |
dc.contributor.author | Ballaro, Riccardo | |
dc.contributor.author | Irajizad, Ehsan | |
dc.contributor.author | Do, Kim-An | |
dc.contributor.author | Maitra, Anirban | |
dc.contributor.author | Zhang, Jianjun | |
dc.contributor.author | Schmidt, C. Max | |
dc.contributor.author | Fahrmann, Johannes F. | |
dc.contributor.department | Surgery, School of Medicine | |
dc.date.accessioned | 2025-02-25T09:34:21Z | |
dc.date.available | 2025-02-25T09:34:21Z | |
dc.date.issued | 2024 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | León-Letelier RA, Chen Y, Ballaro R, et al. A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. J Cancer Immunol (Wilmington). 2024;6(4):148-153. doi:10.33696/cancerimmunol.6.095 | |
dc.identifier.uri | https://hdl.handle.net/1805/45991 | |
dc.language.iso | en_US | |
dc.publisher | Scientific Archives | |
dc.relation.isversionof | 10.33696/cancerimmunol.6.095 | |
dc.relation.journal | Journal of Cancer Immunology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Pancreatic ductal adenocarcinoma (PDAC) | |
dc.subject | Cancer-related deaths | |
dc.subject | Localized disease | |
dc.subject | Metastatic | |
dc.title | A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer | |
dc.type | Article |